BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3977181)

  • 1. The effects of systemic immunization of pulmonary clearance of Pseudomonas aeruginosa.
    Dunn MM; Toews GB; Hart D; Pierce AK
    Am Rev Respir Dis; 1985 Mar; 131(3):426-31. PubMed ID: 3977181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary clearance of Pseudomonas aeruginosa in neutropenic mice. Effects of systemic immunization.
    Dunn MM; Kamp DW
    Am Rev Respir Dis; 1987 Jun; 135(6):1294-9. PubMed ID: 3109290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae.
    Vial WC; Toews GB; Pierce AK
    Am Rev Respir Dis; 1984 Jan; 129(1):87-91. PubMed ID: 6703489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa Or Burkholderia cepacia.
    Sokol PA; Kooi C; Hodges RS; Cachia P; Woods DE
    J Infect Dis; 2000 May; 181(5):1682-92. PubMed ID: 10823769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
    Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
    FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of hyperoxia on pulmonary clearance of Pseudomonas aeruginosa.
    Dunn MM; Smith LJ
    J Infect Dis; 1986 Apr; 153(4):676-81. PubMed ID: 3081661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant.
    Sordelli DO; Cerquetti MC; Hooke AM; Bellanti JA
    Infect Immun; 1983 Mar; 39(3):1275-9. PubMed ID: 6404822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pulmonary clearance of smooth and rough strains of Pseudomonas aeruginosa.
    Martin HG; Warren JR; Dunn MM
    Am Rev Respir Dis; 1989 Jul; 140(1):206-10. PubMed ID: 2502052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial immunity of lower airways: local or localized?
    Franĕk J; Libich J; Malina J
    Folia Microbiol (Praha); 1985; 30(3):247-57. PubMed ID: 3891551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4.
    Buret A; Dunkley M; Clancy RL; Cripps AW
    Infect Immun; 1993 Feb; 61(2):671-9. PubMed ID: 8380797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae.
    McGehee JL; Radolf JD; Toews GB; Hansen EJ
    Am J Respir Cell Mol Biol; 1989 Sep; 1(3):201-10. PubMed ID: 2624760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa.
    Berger M; Norvell TM; Tosi MF; Emancipator SN; Konstan MW; Schreiber JR
    Pediatr Res; 1994 Jan; 35(1):68-77. PubMed ID: 8134202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo.
    Greenberg SS; Zhao X; Hua L; Wang JF; Nelson S; Ouyang J
    Alcohol Clin Exp Res; 1999 Apr; 23(4):735-44. PubMed ID: 10235311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis.
    Walsh CJ; Carey PD; Cook DJ; Bechard DE; Fowler AA; Sugerman HJ
    Surgery; 1991 Aug; 110(2):205-11; discussion 211-2. PubMed ID: 1677491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis.
    Masinick SA; Montgomery CP; Montgomery PC; Hazlett LD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):910-8. PubMed ID: 9112987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
    Ding FM; Zhu SL; Shen C; Jiang YQ
    Respirology; 2012 May; 17(4):727-34. PubMed ID: 22404374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.
    Dunkley ML; Clancy RL; Cripps AW
    Immunology; 1994 Nov; 83(3):362-9. PubMed ID: 7835960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.